Double-Blind Multicenter Randomized Clinical Trial Comparing Glucagon Vs Placebo in the Resolution of Alimentary Esophageal Impaction Christopher Vélez, MD Associate…

Long Term Efficacy and Safety of Dupilumab for Eosinophilic Esophagitis Swathi Eluri, MD, MSCR   Senior Associate Consultant, Mayo Clinic…

On-Demand Vonoprazan for Non-Erosive Reflux Disease Symptoms: A New Option   Christopher Vélez, MD Associate Program Director, Advanced Fellowship in…

Diagnostic Yield of Prolonged Wireless pH vs 24-hour pH-Impedance Monitoring for Evaluation of Chronic Laryngeal Symptoms Swathi Eluri, MD, MSCR…

Vonoprazan is Efficacious for Non-Erosive Reflux Disease (NERD): An Alternative for PPI-Resistant NERD Patients? Christopher Vélez, MD Associate Program Director,…

Swathi Eluri, MD, MSCR takes an evidence-based look at a 2022 article which showed budesonide oral suspension improved outcomes in patients with EoE.

Non-Erosive GERD Does Not Lead to an Increased Risk of Esophageal Adenocarcinoma: A Nordic Population Based Cohort Study Swathi Eluri,…

The goal of surveillance is to identify low-grade or high-grade dysplasia or early cancer at a treatable stage, however, current early cancer detection practices are ineffective. One potential explanation for these limitations is PEEC/PEEN, similar to the concept of post-colonoscopy colorectal cancer and related to endoscopy quality.

Cooking Up Something New With a One-Food Elimination Diet: A Simpler Approach to  Dietary Therapy for Eosinophilic Esophagitis Jennifer M.…

Dupilumab, an IgG4 Monoclonal Antibody, for Eosinophilic Esophagitis: Revising the Treatment Paradigm Afrin Kamal, MD, MS1 and Philip Schoenfeld, MD,…